1. From the Departments of Oncology, Pathology, and Epidemiology, University Hospitals of Leicester NHS Trust; Imperial Cancer Research Fund, Molecular Oncology Unit, Institute of Medicine, John Ratcliffe Hospital, Oxford, United Kingdom; and Institute of Virology, Slovak Academy of Sciences, Slovak Republic.